Oorsprong van het eerstegraads netwerk van Andrea Campanile
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Andrea Campanile via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| REGENXBIO INC. | Pharmaceuticals: Major | Founder | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biosortia Pharmaceuticals, Inc.
 Biosortia Pharmaceuticals, Inc. BiotechnologyHealth Technology Biosortia Pharmaceuticals, Inc. engages as a researching and developing algal technology company. It focuses on commercialization of concentration, dewatering, drying, and extraction of biomass. The company was founded by Ross O. Youngs in 2008 and is headquartered in Columbus, OH. | Biotechnology | Director/Board Member | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Brown University | College/University | Doctorate Degree | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
| WWBD-FM | Broadcasting | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| Albion College | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree | |
| Tufts University | College/University | Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Rockefeller University | College/University | Doctorate Degree | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| F.W. Olin Graduate School of Business | College/University | Masters Business Admin | |
| Yale School of Management | College/University | Masters Business Admin | |
| University of Pittsburgh School of Medicine | College/University | Doctorate Degree | |
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | ||
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Novartis Pharmaceuticals BV
 Novartis Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals BV is a Dutch company that manufactures pharmaceutical products. The private company is based in Arnhem, Netherlands. | Pharmaceuticals: Major | Director of Finance/CFO | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | Medical Distributors | Director/Board Member | |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
CTRL Therapeutics, Inc.
 CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Investment Managers | Director/Board Member | |
Cellevolve Bio
 Cellevolve Bio Pharmaceuticals: MajorHealth Technology Cellevolve Bio is a company that specializes in the development and commercialization of cell therapies. The company is based in San Francisco, CA. The company's mission is to translate innovation into commercially available treatments to accelerate the revolution in cell therapy. Cellevolve understands that cell therapy innovations require unique and specialized capabilities to advance them to approval and beyond. The company was founded by leaders with extensive experience in developing and launching therapeutics. The company was founded by Derrell D. Porter, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Zwitserland | 6 |
| Verenigd Koninkrijk | 5 |
| Nederland | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 19 |
| Finance | 3 |
| Distribution Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 45 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 21 |
| Chief Executive Officer | 12 |
| Undergraduate Degree | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Maxine Gowen | 23 |
| Sandipkumar S. Kapadia | 19 |
| Athena Countouriotis | 17 |
| Saqib Islam | 15 |
| Derrell Porter | 14 |
| Alex Fotopoulos | 7 |
| James M. Wilson | 6 |
| Stuart M. Henderson | 5 |
| Edgar Cale | 5 |
| William Chou | 5 |
| Mark Forman | 4 |
| Kathleen Borthwick | 3 |
| Dolan Sondhi | 3 |
- Beurs
- Insiders
- Andrea Campanile
- Bedrijfsconnecties
